<DOC>
	<DOCNO>NCT01241097</DOCNO>
	<brief_summary>- To test hypothesis therapy high dose statin provide endothelial superior benefit cholesterol lower low-dose statin combine ezetimibe . - To test hypothesis therapy high dose statin provide anti-inflammatory effect reduction cholesterol low dose statin plus ezetimibe</brief_summary>
	<brief_title>Pleiotropism Statin Therapy High Dose Versus Low Dose Combined With Ezetimibe</brief_title>
	<detailed_description>Randomized , double-blind , placebo-controlled study . Inclusion Criteria : Obese woman body mass index ( BMI ) &gt; 25 kg / m² , age 18 year LDL-C &gt; 100 mg / dl For treatment simvastatin 80 mg , participant receive two identical vial , contain simvastatin 40 mg. For treatment combination simvastatin 10 mg ezetimibe 10 mg , participant receive two identical bottle , one bottle simvastatin 10 mg , another bottle ezetimibe 10mg . In control group , participant receive two identical bottle , bottle contain inert tablet . Each group 20 participant . Dependent Variable ( Final Primary Outcome ) : Percentage change vasodilation brachial artery flow-mediated , treatment eight week . Covariates : clinical , biochemical marker ultrasound .</detailed_description>
	<mesh_term>Ezetimibe</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Women body mass index ( BMI ) &gt; 25 kg / m² Aged &gt; 18 year LDLC &gt; 100 mg / dl Previous use statin , fibrates ezetimibe Triglycerides &gt; 400 mg / dl Serum creatinine great 2.0 md / dl Elevated liver enzymes , one half time upper limit normal Creatine kinase ( CK ) level three time upper limit normal Pregnant Breastfeeding Heart failure Psychiatric disorder Hormone replacement therapy . The occurrence recent onset within last four week treatment betablockers , convert enzyme inhibitor calcium channel blocker , intervention undertaken period least four week continuous use . Acute inflammatory process last month , assess clinical history physical examination ( ear , throat , skin lesion inflammatory manifestation ) well report chronic disease collagen , occurrence active tuberculosis last three month exclude work .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>endothelial function</keyword>
	<keyword>statin</keyword>
	<keyword>ezetimibe</keyword>
	<keyword>pleiotropism</keyword>
</DOC>